Mabtech

Mabtech is a Swedish biotechnology company founded in 1986, specializing in the development and manufacturing of high-quality immunoassays for life science research.

Headquartered in Nacka Strand, Stockholm, Mabtech has expanded its reach with a U.S. office in Cincinnati, Ohio, and serves over 900 customers across 60 countries. The company focuses on providing innovative tools for understanding immune responses, particularly through its expertise in monoclonal antibodies for ELISpot, FluoroSpot, and ELISA applications. Mabtech offers a range of services, including immunoassay development, custom antibody solutions, and scientific consultation. Their product portfolio features high-sensitivity kits for studying immune responses, such as ELISpot and FluoroSpot kits, as well as automated readers for data acquisition. The company adheres to strict quality control standards and has launched a CE-labelled IVD test for COVID-19, showcasing its capabilities in regulated medical diagnostics. With a dedicated team of approximately 108 employees, Mabtech continues to support advancements in biomedical science and therapeutic monitoring.